| 标题 |
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The lancet. Gastroenterology & hepatology 作者:Shi Y; Han G; Zhou J; Shi X; Jia W; et al 出版日期:2025/07/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)